USPTO trademark

PERSPECTIVE THERAPEUTICS

Opposition periodUSPTOWord markClass 1Class 5Class 42

"PERSPECTIVE THERAPEUTICS" is a word mark owned by Perspective Therapeutics, Inc., filed at the USPTO on June 23, 2026. It is in its opposition period and covers classes 1, 5 and 42.

View Perspective Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
PERSPECTIVE THERAPEUTICS trademark as filed
As filed with the USPTO
Status
Opposition period
Since October 20, 2026
Filed
June 23, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99900187
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns PERSPECTIVE THERAPEUTICS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Perspective Therapeutics, Inc.

CATX · Seattle, United States

9 trademarks in the portfolioView company

Representative

Sandra L Etherton

Etherton Law Group, LLC

Goods and services

What the mark covers

The products and services PERSPECTIVE THERAPEUTICS is filed for, grouped by Nice class.

  • Active chemical ingredients for use in the manufacture of anti-cancer drugs; radiopharmaceutical chemical compounds for use in the manufacture of radiopharmaceutical preparations and anti-cancer drugs and for pharmaceutical research and development; radiolabeled chemical compounds comprising alpha-emitting radionuclides for use in the manufacture of radiopharmaceutical preparations and anti-cancer drugs and for pharmaceutical research and development; bifunctional chelating agents for conjugating radionuclides to targeting molecules for use in the manufacture of radiopharmaceutical preparations and anti-cancer drugs and for pharmaceutical research and development; chemical precursors for use in the manufacture of radiopharmaceuticals; chelating compounds for radiolabeling of peptides and small molecules; radioactive isotope-labeled chemical intermediates for pharmaceutical research and manufacturing

  • Pharmaceutical products for the treatment of cancer; radiopharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for the diagnosis of cancer; targeted alpha therapy radiopharmaceutical preparations for the treatment of cancer comprising prostate cancer, breast cancer, pancreatic cancer, colorectal cancer, or neuroendocrine tumors; radioligand therapy preparations comprising radiolabeled targeting compounds for oncological use; radiopharmaceutical diagnostic agents for use in nuclear medicine imaging; radiopharmaceutical preparations for the treatment of cancers; radiolabeled peptide conjugates for use in cancer therapy; radiopharmaceutical preparations for theranostic applications in oncology

  • Medical and scientific research in the field of cancer treatment and diagnosis; scientific research and development services in the field of radiopharmaceuticals and nuclear medicine; scientific contract research services in the field of radiopharmaceutical drug discovery and development; preclinical research and development services relating to radiolabeled compounds for cancer therapy and diagnosis; scientific consultation services in the field of targeted radionuclide therapy; laboratory research services in the field of radiochemistry and radiopharmaceutical development; drug discovery research services in the field of oncology radiopharmaceuticals; scientific research and technological services relating to the development of targeted alpha therapy compounds; research and development services relating to theranostic radiopharmaceutical platforms

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Teas/email correspondence entered
  6. Correspondence received in law office
  7. Teas response to office action received
  8. Notification of non-final action e-mailed
  9. Non-final action e-mailed
  10. Non-final action written

4 earlier steps on the official record.

FAQ

About PERSPECTIVE THERAPEUTICS

Who owns the trademark "PERSPECTIVE THERAPEUTICS"?

The USPTO trademark "PERSPECTIVE THERAPEUTICS" (application 99900187) is owned by Perspective Therapeutics, Inc.

What is the status of "PERSPECTIVE THERAPEUTICS"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PERSPECTIVE THERAPEUTICS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019efd36-1c37-700a-af5f-e4a267963783
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019efd36-1c37-700a-af5f-e4a267963783",
  "object": "trademark",
  "mark_text": "PERSPECTIVE THERAPEUTICS",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99900187",
  "filing_date": "2026-06-23",
  "nice_classes": [
    1,
    5,
    42
  ],
  "owners": [
    {
      "name": "Perspective Therapeutics, Inc.",
      "entity_id": "ent_019eb71e-ff8e-77cb-847f-405458050095"
    }
  ]
}